Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia

Haematologica

Volumn 85, Issue 11, 2000, Pages 1140-1145

  Lopez Matas, M ^a   Rodriguez Justo, M ^a   Morilla, R ^a   Catovsky, D ^a   Matutes, E ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

CD21; CD23; CLL; CLL PL; Quantitative flow cytometry

Indexed keywords

CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE ACTIVATION; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; LEUKEMIA CELL; MAJOR CLINICAL STUDY;

BONE MARROW CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, B-CELL; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; STATISTICS, NONPARAMETRIC;

EID: 0033652964     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. CD23 and B-cell activation
2. Effect of B-cell stimulatory factor-1 (interleukin 4) of Fc ε and Fc γ receptor expression on murine B-lymphocytes and B cell lines
3. Recombinant 25-kDa CD23 and interleukin 1a promote the survival of germinal center B cells: Evidence for bifurcation in the development of centrocytes rescued from apoptosis
4. Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23
5. CD21 is a ligand for CD23 and regulates IgE production
6. The low-affinity receptor for IgE
7. CD23 antigen regulation and signaling in chronic lymphocytic leukaemia
8. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation
9. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia
10. The immunological profile or B-cell disorders and proposal of a scoring system for the diagnosis of CLL
11. Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lyrephocytic leukaemia
12. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia
13. High expression of CD23 in the proliferation centers of chronic lymphocytic leukaemia in lymph nodes and spleen
14. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias
15. Trisomy 12 defines a group of CLL with atypical morphology: Correlation between cytogenetic, clinical and laboratory features in 544 patients
16. A clinical staging system for chronic lymphocytic leukemia: Prognostic significance
17. Prognostic significance of membrane antigens and morphology in chronic lymphocytic leukaemia
18. Atypical lymphocyte morphology: An adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12
19. Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia
20. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3δγ and EBV
21. Prognostic factors in chronic lymphocytic leukaemia
22. Morphology, atypical chronic lymphocytic leukaemia and prognostic features affecting choice of therapy